-
New Biologic Drug Approved for Moderate to Severe Atopic Dermatitis
The FDA approved tralokinumab-ldrm (Adbry), a biologic for the treatment of moderate-to-severe atopic dermatitis in adults 18 years…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
-
FDA Releases Updated Women’s Health Research Roadmap
-
Counterfeit Prescriptions from Online Pharmacies Are Posing a Health Risk
-
Compounding Group Sues FDA for Removing Weight-Loss Medications from Short-Supply List
-
New Approach Announced for Processing Complaints to the FDA
-
When, Why, and How to Prescribe During Cold and Flu Season
-
Tips for Landing Your First Nurse Practitioner Job
-
How Teamwork Can Help Prevent Malpractice Incidents for Nurse Practitioners
-
Sharpen Your Sherlock Skills: Mastering the Art of the Differential Diagnosis
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.